Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix

Cell Death

Danial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651

Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death

Wei, M. C., Zong, W.-X., Cheng, E. H.-Y., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B., & Korsmeyer, S. J. (2001) · Science · doi:10.1126/science.1059108 · Cited by 3,988

Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors

Luo, X., Budihardjo, I., Zou, H., Slaughter, C., & Wang, X. (1998) · Cell · doi:10.1016/s0092-8674(00)81589-5 · Cited by 3,626

In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse

Schwarze, S. R., Ho, A. L., Vocero-Akbani, A. M., & Dowdy, S. F. (1999) · Science · doi:10.1126/science.285.5433.1569 · Cited by 2,418

Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain

Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206

The third helix of the Antennapedia homeodomain translocates through biological membranes.

Derossi, D., Joliot, A., Chassaing, G., & Prochiantz, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34080-2 · Cited by 2,034

Involvement of the bcl -2 Gene in Human Follicular Lymphoma

Tsujimoto, Y., Cossman, J., Jaffe, E. S., & Croce, C. M. (1985) · Science · doi:10.1126/science.3874430 · Cited by 1,787

Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis

Wadia, J. S., Stan, R. V., & Dowdy, S. F. (2004) · Nature Medicine · doi:10.1038/nm996 · Cited by 1,647

Structure of Bcl-x L -Bak Peptide Complex: Recognition Between Regulators of Apoptosis

Sattler, M., Liang, H., Nettesheim, D., Meadows, R. P., Harlan, J. E., Eberstadt, M., Yoon, H. S., Shuker, S. B., Chang, B. S., Minn, A. J., et al. (1997) · Science · doi:10.1126/science.275.5302.983 · Cited by 1,476

X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death

Muchmore, S. W., Sattler, M., Liang, H., Meadows, R. P., Harlan, J. E., Yoon, H. S., Nettesheim, D. G., Chang, B. S., Thompson, C. B., Wong, S., et al. (1996) · Nature · doi:10.1038/381335a0 · Cited by 1,467

Oncogenic Role of KIAA0101 Interacting with Proliferating Cell Nuclear Antigen in Pancreatic Cancer

Hosokawa, M., Takehara, A., Matsuda, K., Eguchi, H., Ohigashi, H., Ishikawa, O., Shinomura, Y., Imai, K., Nakamura, Y., & Nakagawa, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4356 · Cited by 94

Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review

Bajwa, N., Liao, C., & Nikolovska‐Coleska, Z. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2012.644274 · Cited by 94

Photocontrollable Peptide‐Based Switches Target the Anti‐Apoptotic Protein Bcl‐xL

Kneissl, S., Loveridge, E. J., Williams, C., Crump, M. P., & Allemann, R. K. (2008) · ChemBioChem · doi:10.1002/cbic.200800502 · Cited by 93

Organoids to Study Intestinal Nutrient Transport, Drug Uptake and Metabolism – Update to the Human Model and Expansion of Applications

Zietek, T., Giesbertz, P., Ewers, M., Reichart, F., Weinmüller, M., Urbauer, E., Haller, D., Demir, İ. E., Ceyhan, G. O., Kessler, H., et al. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.577656 · Cited by 92

Apoptotic Pathways in Tumor Progression and Therapy

Melet, A., Song, K., Bucur, O., Jagani, Z., Grassian, A. R., & Khosravi‐Far, R. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-1-4020-6554-5_4 · Cited by 92

Big wheel keeps on turning: apoptosome regulation and its role in chemoresistance

Fadeel, B., Ottosson, A., & Pervaiz, S. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402265 · Cited by 95

Defects of the apoptotic pathway as therapeutic target against cancer

Mashima, T., & Tsuruo, T. (2005) · Drug Resistance Updates · doi:10.1016/j.drup.2005.11.001 · Cited by 92

Bid chimeras indicate that most BH3-only proteins can directly activate Bak and Bax, and show no preference for Bak versus Bax

Hockings, C., Anwari, K., Ninnis, R. L., Brouwer, J. M., O’Hely, M., Evangelista, M., Hinds, M. G., Czabotar, P. E., Lee, E. F., Fairlie, W. D., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.105 · Cited by 95

Therapeutic targeting of apoptosis pathways in cancer

Ziegler, D. S., & Kung, A. L. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3282f310f6 · Cited by 92

Perfluoroarene–Based Peptide Macrocycles to Enhance Penetration Across the Blood–Brain Barrier

Fadzen, C. M., Wolfe, J. M., Cho, C., Chiocca, E. A., Lawler, S. E., & Pentelute, B. L. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b09790 · Cited by 93

Strukturbasierte Entwicklung von Protein‐Protein‐Interaktionsinhibitoren: Stabilisierung und Nachahmung von Peptidliganden

Pelay‐Gimeno, M., Glas, A., Koch, O., & Grossmann, T. N. (2015) · Angewandte Chemie · doi:10.1002/ange.201412070 · Cited by 90

Progress and perspectives on directing group-assisted palladium-catalysed C–H functionalisation of amino acids and peptides

Shabani, S., Wu, Y., Ryan, H. G., & Hutton, C. A. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01441a · Cited by 90

Targeting recognition surfaces on natural proteins with peptidic foldamers

Checco, J. W., & Gellman, S. H. (2016) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2016.06.014 · Cited by 88

Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection In Vitro

Curreli, F., Victor, S. M. B., Ahmed, S., Drelich, A. K., Tong, X., Tseng, C.-T. K., Hillyer, C. D., & Debnath, A. K. (2020) · mBio · doi:10.1128/mbio.02451-20 · Cited by 91

Stapled RGD Peptide Enables Glioma-Targeted Drug Delivery by Overcoming Multiple Barriers

Ruan, H., Chen, X., Xie, C., Li, B., Man, Y. M., Liu, Y., Zhang, M., Zhang, X., Zhan, C., Lu, W., et al. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b03682 · Cited by 90

Achieving cell penetration with distance-matching cysteine cross-linkers: a facile route to cell-permeable peptide dual inhibitors of Mdm2/Mdmx

Muppidi, A., Wang, Z., Li, X., Chen, J., & Lin, Q. (2011) · Chemical Communications · doi:10.1039/c1cc13320a · Cited by 87

Bcl-2 family members as molecular targets in cancer therapy

Marzo, I., & Naval, J. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.06.009 · Cited by 87

Chemical Synthesis of Hydrocarbon‐Stapled Peptides for Protein Interaction Research and Therapeutic Targeting

Bird, G. H., Crannell, W. C., & Walensky, L. D. (2011) · Current Protocols in Chemical Biology · doi:10.1002/9780470559277.ch110042 · Cited by 89

Phage Selection of Chemically Stabilized α-Helical Peptide Ligands

Diderich, P., Bertoldo, D., Dessen, P., Maola, K. M. G., Pizzitola, I., Held, W., Huelsken, J., & Heinis, C. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00963 · Cited by 88

NS5A - From Obscurity to New Target for HCV Therapy

Schmitz, U., & Tan, S. (2008) · Recent Patents on Anti-Infective Drug Discovery · doi:10.2174/157489108784746597 · Cited by 86

Direct Targeting of Rab‐GTPase–Effector Interactions

Spiegel, J., Cromm, P. M., Itzen, A., Goody, R. S., Grossmann, T. N., & Waldmann, H. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201308568 · Cited by 88

Macrocyclic Control in Helix Mimetics

Guarracino, D. A., Riordan, J. A., Barreto, G. M., Oldfield, A. L., Kouba, C. M., & Agrinsoni, D. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00623 · Cited by 89

Converting disulfide bridges in native peptides to stable methylene thioacetals

Kourra, C. M. B. K., & Cramer, N. (2016) · Chemical Science · doi:10.1039/c6sc02285e · Cited by 88

Selective Covalent Targeting of Anti-Apoptotic BFL-1 by Cysteine-Reactive Stapled Peptide Inhibitors

Huhn, A. J., Guerra, R. M., Harvey, E. P., Bird, G. H., & Walensky, L. D. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.07.022 · Cited by 85

Therapeutic stapled peptides: Efficacy and molecular targets

Li, Y., Wu, M., Fu, Y., Xue, J., Yuan, F., Qu, T., Rissanou, A. N., Wang, Y., Li, X., & Hu, H. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107137 · Cited by 86

Stereochemical effects of all-hydrocarbon tethers in i,i+4 stapled peptides

Kim, Y., & Verdine, G. L. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.03.022 · Cited by 86

Biological responses towards cationic peptides and drug carriers

Verdurmen, W. P. R., & Brock, R. E. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.11.005 · Cited by 85

The daily job of night killers: alternative roles of the BCL-2 family in organelle physiology

Hetz, C. A., & Glimcher, L. H. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.10.003 · Cited by 86

Z-Selective Olefin Metathesis on Peptides: Investigation of Side-Chain Influence, Preorganization, and Guidelines in Substrate Selection

Mangold, S. L., O’Leary, D. J., & Grubbs, R. H. (2014) · Journal of the American Chemical Society · doi:10.1021/ja507166g · Cited by 84

An evidence-based review of obatoclax mesylate in the treatment of hematological malignancies

Goard, C. A., & Schimmer, A. D. (2013) · Core evidence · doi:10.2147/ce.s42568 · Cited by 84

Inhibiting protein–protein interactions using designed molecules

Zhao, L., & Chmielewski, J. A. (2005) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2005.01.005 · Cited by 84

A two-component 'double-click' approach to peptide stapling

Lau, Y. H., Wu, Y., de Andrade, P., Galloway, W. R. J. D., & Spring, D. R. (2015) · Nature Protocols · doi:10.1038/nprot.2015.033 · Cited by 84

Enhancing the Cell Permeability of Stapled Peptides with a Cyclic Cell-Penetrating Peptide

Dougherty, P. G., Wen, J., Pan, X., Koley, A., Ren, J.-G., Sahni, A., Basu, R., Salim, H., Kubi, G. A., Qian, Z., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00456 · Cited by 87

Cys–Cys and Cys–Lys Stapling of Unprotected Peptides Enabled by Hypervalent Iodine Reagents

Ceballos, J., Grinhagena, E., Sangouard, G., Heinis, C., & Waser, J. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202014511 · Cited by 85

A Membrane-targeted BID BCL-2 Homology 3 Peptide Is Sufficient for High Potency Activation of BAX in Vitro

Oh, K. J., Barbuto, S., Pitter, K. L., Morash, J. G., Walensky, L. D., & Korsmeyer, S. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602341200 · Cited by 83

Intrinsically Disordered Proteins in Bcl-2 Regulated Apoptosis

Rautureau, G. J. P., Day, C. L., & Hinds, M. G. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11041808 · Cited by 91

N-alkylated oligoamide α-helical proteomimetics

Campbell, F., Plante, J. P., Edwards, T. A., Warriner, S. L., & Wilson, A. J. (2010) · Organic & Biomolecular Chemistry · doi:10.1039/c001164a · Cited by 82

Helix-mediated protein–protein interactions as targets for intervention using foldamers

Edwards, T. A., & Wilson, A. J. (2011) · Amino Acids · doi:10.1007/s00726-011-0880-8 · Cited by 88

Selective Recapitulation of Conserved and Nonconserved Regions of Putative NOXA1 Protein Activation Domain Confers Isoform-specific Inhibition of Nox1 Oxidase and Attenuation of Endothelial Cell Migration

Ranayhossaini, D., Rodriguez, A. I., Sahoo, S., Chen, B. B., Mallampalli, R. K., Kelley, E. E., Csányi, G., Gladwin, M. T., Romero, G. G., & Pagano, P. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.521344 · Cited by 83

Expanding Circle of Inhibition: Small-Molecule Inhibitors of Bcl-2 as Anticancer Cell and Antiangiogenic Agents

Zeitlin, B. D., Zeitlin, I. J., & Nor, J. E. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.7693 · Cited by 81

Therapeutic Potential of VIVIT, a Selective Peptide Inhibitor of Nuclear Factor of Activated T cells, in Cardiovascular Disorders

Yu, H., van Berkel, T. J. C., & Biessen, E. A. L. (2007) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2007.00011.x · Cited by 82

Modulating the Bcl-2 Family of Apoptosis Suppressors for Potential Therapeutic Benefit in Cancer

Shore, G. C., & Viallet, J. (2005) · Hematology · doi:10.1182/asheducation-2005.1.226 · Cited by 81

Iterative optimization yields Mcl-1–targeting stapled peptides with selective cytotoxicity to Mcl-1–dependent cancer cells

Araghi, R. R., Bird, G. H., Ryan, J. A., Jenson, J. M., Godes, M., Pritz, J. R., Grant, R. A., Letai, A. G., Walensky, L. D., & Keating, A. E. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1712952115 · Cited by 83

Development of a Peptide that Selectively Activates Protein Phosphatase‐1 in Living Cells

Chatterjee, J., Beullens, M., Sukackaitė, R., Qian, J., Lesage, B., Hart, D. J., Bollen, M., & Köhn, M. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201204308 · Cited by 83

Introducing the Petasis Reaction for Late‐Stage Multicomponent Diversification, Labeling, and Stapling of Peptides

Ricardo, M. G., Llanes, D., Wessjohann, L. A., & Rivera, D. G. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201812620 · Cited by 81

Small molecule modulators of protein-protein interactions: selected case studies

Aeluri, M., Chamakuri, S., Dasari, B., Guduru, S. K. R., Jimmidi, R., Jogula, S., & Arya, P. (2014) · Chemical Reviews · doi:10.1021/cr4004049 · Cited by 79

From Laptop to Benchtop to Bedside: Structure-based Drug Design on Protein Targets

Chen, L., Morrow, J. K., Tran, H. T., Phatak, S. S., Du‐Cuny, L., & Zhang, S. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799436386 · Cited by 81

Twin disulfides for orthogonal disulfide pairing and the directed folding of multicyclic peptides

Wu, C., Leroux, J., & Gauthier, M. A. (2012) · Nature Chemistry · doi:10.1038/nchem.1487 · Cited by 79

Genetically Encoded Alkenes in Yeast

Ai, H., Shen, W., Brustad, E. M., & Schultz, P. G. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200905590 · Cited by 79

Microvascular NADPH oxidase in health and disease

Li, Y., & Pagano, P. J. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.02.049 · Cited by 79

Targeting programmed cell death pathways with experimental therapeutics: opportunities in high-risk neuroblastoma

Goldsmith, K. C., & Hogarty, M. D. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.01.048 · Cited by 79

Lead discovery and optimization strategies for peptide macrocycles

Bhat, A., Roberts, L. R., & Dwyer, J. J. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.07.083 · Cited by 78

Dendrimer Space Exploration: An Assessment of Dendrimers/Dendritic Scaffolding as Inhibitors of Protein–Protein Interactions, a Potential New Area of Pharmaceutical Development

Mignani, S. M., Kazzouli, S. E., Bousmina, M., & Majoral, J. (2013) · Chemical Reviews · doi:10.1021/cr400362r · Cited by 78

Peptidomimetics: A Synthetic Tool for Inhibiting Protein–Protein Interactions in Cancer

Mabonga, L., & Kappo, A. P. (2019) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-019-09831-5 · Cited by 81

Cooperative Stapling of Native Peptides at Lysine and Tyrosine or Arginine with Formaldehyde

Li, B., Tang, H., Turlik, A., Wan, Z., Xue, X., Li, L., Yang, X., Li, J., He, G., Houk, K. N., et al. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202016267 · Cited by 78

PROTACs: Current and Future Potential as a Precision Medicine Strategy to Combat Cancer

Rutherford, K. A., & McManus, K. J. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0747 · Cited by 86

Targeting BIG3–PHB2 interaction to overcome tamoxifen resistance in breast cancer cells

Yoshimaru, T., Komatsu, M., Matsuo, T., Chen, Y., Murakami, Y., Mizuguchi, K., Mizohata, E., Tsuyoshi Inoue, A., Akiyama, M. O., Yamaguchi, R., et al. (2013) · Nature Communications · doi:10.1038/ncomms3443 · Cited by 78

Rationally Designed Inhibitors Identify STAT3 N-Domain as a Promising Anticancer Drug Target

Timofeeva, O. A., Gaponenko, V., Lockett, S., Tarasov, S. G., Jiang, S., Michejda, C. J., Perantoni, A. O., & Tarasova, N. I. (2007) · ACS Chemical Biology · doi:10.1021/cb700186x · Cited by 79

Classes of Cell-Penetrating Peptides

Pooga, M., & Langel, Ü. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2806-4_1 · Cited by 81

Bioconjugation – using selective chemistry to enhance the properties of proteins and peptides as therapeutics and carriers

Gunnoo, S. B., & Madder, A. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c6ob00808a · Cited by 79

Exploration of Backbone Space in Foldamers Containing α‐ and β‐Amino Acid Residues: Developing Protease‐Resistant Oligomers that Bind Tightly to the BH3‐Recognition Cleft of Bcl‐xL

Sadowsky, J., Murray, J. K., Tomita, Y. A., & Gellman, S. H. (2007) · ChemBioChem · doi:10.1002/cbic.200600546 · Cited by 77

Facile synthesis of stapled, structurally reinforced peptide helices via a photoinduced intramolecular 1,3-dipolar cycloaddition reaction

Madden, M. M., Vera, C. I. R., Song, W., & Lin, Q. (2009) · Chemical Communications · doi:10.1039/b912094g · Cited by 78

Stapled HIV-1 peptides recapitulate antigenic structures and engage broadly neutralizing antibodies

Bird, G. H., Irimia, A., Ofek, G., Kwong, P. D., Wilson, I. A., & Walensky, L. D. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2922 · Cited by 81

Vinylphosphonites for Staudinger-induced chemoselective peptide cyclization and functionalization

Kasper, M., Glanz, M., Oder, A., Schmieder, P., von Kries, J. P., & Hackenberger, C. P. R. (2019) · Chemical Science · doi:10.1039/c9sc01345h · Cited by 76

Tumor Therapy Mediated by Lentiviral Expression of shBcl-2 and S-TRAIL

Kock, N., Kasmieh, R., Weissleder, R., & Shah, K. (2007) · Neoplasia · doi:10.1593/neo.07223 · Cited by 76

Hydrocarbon constrained peptides – understanding preorganisation and binding affinity

Miles, J. A., Yeo, D. J., Rowell, P. R., Rodriguez‐Marin, S., Pask, C. M., Warriner, S. L., Edwards, T. A., & Wilson, A. J. (2016) · Chemical Science · doi:10.1039/c5sc04048e · Cited by 77

Hydrophile scanning as a complement to alanine scanning for exploring and manipulating protein–protein recognition: Application to the Bim BH3 domain

Boersma, M., Sadowsky, J., Tomita, Y. A., & Gellman, S. H. (2008) · Protein Science · doi:10.1110/ps.032896.107 · Cited by 75

Constitutive proteasome-mediated turnover of Bfl-1/A1 and its processing in response to TNF receptor activation in FL5.12 pro-B cells convert it into a prodeath factor

Kucharczak, J., Simmons, M. J., Duckett, C. S., & Gélinas, C. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401684 · Cited by 75

Macrocyclized Extended Peptides: Inhibiting the Substrate-Recognition Domain of Tankyrase

Xu, W., Lau, Y. H., Fischer, G. W., Tan, Y. S., Chattopadhyay, A., de la Roche, M., Hyvönen, M., Verma, C. S., Spring, D. R., & Itzhaki, L. S. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b10234 · Cited by 75

Exploitation of peptide motif sequences and their use in nanobiotechnology

Shiba, K. (2010) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2010.07.008 · Cited by 75

Inhibitors of the p53/hdm2 protein–protein interaction—path to the clinic

Carry, J., & García-Echeverría, C. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.03.034 · Cited by 73

Crosslinked Aspartic Acids as Helix‐Nucleating Templates

Zhao, H., Liu, Q., Geng, H. R., Tian, Y., Cheng, M., Jiang, Y., Xie, M., Niu, X., Jiang, F., Zhang, Y., et al. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201606833 · Cited by 74

Fixierung cyclischer Peptide: Mimetika von Proteinstrukturmotiven

Hill, T. A., Shepherd, N. E., Diness, F., & Fairlie, D. P. (2014) · Angewandte Chemie · doi:10.1002/ange.201401058 · Cited by 72

Targeting protein−protein interfaces using macrocyclic peptides

Gao, M., Cheng, K., & Yin, H. H. (2015) · Biopolymers · doi:10.1002/bip.22625 · Cited by 72

BCL-2: Long and winding path from discovery to therapeutic target

Schenk, R. L., Strasser, A., & Dewson, G. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.10.100 · Cited by 74

Regulation of apoptosis: uncovering the binding determinants

Hinds, M. G., & Day, C. L. (2005) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2005.10.003 · Cited by 72

Stabilized helical peptides: overview of the technologies and therapeutic promises

Estieu‐Gionnet, K., & Guichard, G. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.603723 · Cited by 75

Dithiocarbamate-inspired side chain stapling chemistry for peptide drug design

Li, X., Tolbert, W. D., Hu, H., Gohain, N., Zou, Y., Niu, F., He, W., Yuan, W., Su, J., Pazgier, M., et al. (2018) · Chemical Science · doi:10.1039/c8sc03275k · Cited by 73

All-hydrocarbon stapled peptides as Synthetic Cell-Accessible Mini-Proteins

Verdine, G. L., & Hilinski, G. J. (2012) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2012.01.004 · Cited by 70

Engineering a long-acting, potent GLP-1 analog for microstructure-based transdermal delivery

Yang, P., Zou, H., Chao, E., Sherwood, L., Núñez, V., Keeney, M., Ghartey-Tagoe, E. B., Ding, Z., Quirino, H., Luo, X., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601653113 · Cited by 69

Mitochondrial factors with dual roles in death and survival

Cheng, W.-C., Berman, S., Ivanovska, I. L., Jonas, E. A., Lee, S., Chen, Y., Kaczmarek, L. K., Pineda, F. J., & Hardwick, J. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209596 · Cited by 71

Multimodal Interaction with BCL-2 Family Proteins Underlies the Proapoptotic Activity of PUMA BH3

Edwards, A., Gavathiotis, E., LaBelle, J. L., Braun, C. R., Opoku-Nsiah, K., Bird, G. H., & Walensky, L. D. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.06.007 · Cited by 70

Mucosal delivery of a double-stapled RSV peptide prevents nasopulmonary infection

Bird, G. H., Boyapalle, S., Wong, T. M., Opoku-Nsiah, K., Bedi, R., Crannell, W. C., Perry, A. F., Nguyen, H. D., Sampayo-Escobar, V., Devareddy, A., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71856 · Cited by 73

Mechanistic Studies on the Substrate-Tolerant Lanthipeptide Synthetase ProcM

Mukherjee, S., & van der Donk, W. A. (2014) · Journal of the American Chemical Society · doi:10.1021/ja504692v · Cited by 68

Stability of peptides and therapeutic success in cancer

Pernot, M., Vanderesse, R., Frochot, C., Guillemin, F. H., & Barberi‐Heyob, M. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.574126 · Cited by 67

Aqueous olefin metathesis: recent developments and applications

Sabatino, V., & Ward, T. R. (2019) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.15.39 · Cited by 67

Combination Bcl-2 Antisense and Radiation Therapy for Nasopharyngeal Cancer

Yip, K. W., Mocanu, J. D., Au, P. Y. B., Sleep, G. T., Huang, D. P., Busson, P., Yeh, W., Gilbert, R. W., O’Sullivan, B., Gullane, P. J., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1266 · Cited by 67

Plucking the high hanging fruit: A systematic approach for targeting protein–protein interactions

Raj, M., Bullock, B. N., & Arora, P. S. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.11.023 · Cited by 66

Parallel β-Sheet Secondary Structure Is Stabilized and Terminated by Interstrand Disulfide Cross-Linking

Almeida, A. M., Li, R., & Gellman, S. H. (2011) · Journal of the American Chemical Society · doi:10.1021/ja208856c · Cited by 67

Development of small molecules designed to modulate protein–protein interactions

Che, Y., Brooks, B. R., & Marshall, G. R. (2006) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-006-9040-8 · Cited by 67

Targeting the WASF3–CYFIP1 Complex Using Stapled Peptides Suppresses Cancer Cell Invasion

Teng, Y., Bahassan, A., Dong, D., Hanold, L. E., Ren, X., Kennedy, E. J., & Cowell, J. K. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1680 · Cited by 67

Structure‐Guided Rational Design of α/β‐Peptide Foldamers with High Affinity for BCL‐2 Family Prosurvival Proteins

Smith, B. J., Lee, E. F., Checco, J. W., Evangelista, M., Gellman, S. H., & Fairlie, W. D. (2013) · ChemBioChem · doi:10.1002/cbic.201300351 · Cited by 65

Homogeneous Oligomers of Pro-apoptotic BAX Reveal Structural Determinants of Mitochondrial Membrane Permeabilization

Hauseman, Z. J., Harvey, E. P., Newman, C. E., Wales, T. E., Bucci, J. C., Mintseris, J., Schweppe, D. K., David, L., Fan, L., Cohen, D. T., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.05.029 · Cited by 66

Amphipathic Peptide-Based Fusion Peptides and Immunoconjugates for the Targeted Ablation of Prostate Cancer Cells

Rege, K., Patel, S. J., Megeed, Z., & Yarmush, M. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3658 · Cited by 65

Modular Assembly of Macrocyclic Organo–Peptide Hybrids Using Synthetic and Genetically Encoded Precursors

Smith, J. M., Vitali, F., Archer, S. A., & Fasan, R. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201101331 · Cited by 65

Bent into shape: Folded peptides to mimic protein structure and modulate protein function

Merritt, H. I., Sawyer, N., & Arora, P. S. (2020) · Peptide Science · doi:10.1002/pep2.24145 · Cited by 65

Apoptosis in the treatment of cancer: a promise kept?

Meng, X. W., Lee, S. H., & Kaufmann, S. H. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.10.008 · Cited by 65

BCL2 Is a Downstream Effector of MIZ-1 Essential for Blocking c-MYC-induced Apoptosis

Patel, J. H., & McMahon, S. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609138200 · Cited by 68

Expression and Function of Bcl-2 Proteins in Melanoma

Eberle, J., & Hossini, A. M. (2008) · Current Genomics · doi:10.2174/138920208785699571 · Cited by 66

Serum Stable Natural Peptides Designed by mRNA Display

Howell, S. M., Fiacco, S. V., Takahashi, T. T., Jalali‐Yazdi, F., Millward, S. W., Hu, B., Wang, P., & Roberts, R. W. (2014) · Scientific Reports · doi:10.1038/srep06008 · Cited by 64

Anti-Leukemic Potency of Stapled BH3 Helices Correlates with Their Capacity for Bifunctional Activation of Apoptotic Pathways.

Walensky, L. D., Pitter, K. L., Morash, J. G., Verdine, G. L., & Korsmeyer, S. J. (2006) · Blood · doi:10.1182/blood.v108.11.711.711

Abstract SY37-01: Dissecting the canonical and noncanonical interactions of the BCL-2 family for therapeutic benefit

Walensky, L. D. (2014) · Cancer Research · doi:10.1158/1538-7445.am2014-sy37-01

Dissecting the BCL‐2 family interaction network with stapled peptides: mechanistic insights and pharmacologic opportunities

Walensky, L. D. (2012) · The FASEB Journal · doi:10.1096/fasebj.26.1_supplement.220.1

Abstract 4611: Multimodal activation of apoptosis by a hydrocarbon-stapled PUMA BH3 helix.

Edwards, A., Gavathiotis, E., LaBelle, J. L., Braun, C. R., Opoku-Nsiah, K., Bird, G. H., & Walensky, L. D. (2013) · Cancer Research · doi:10.1158/1538-7445.am2013-4611 · Cited by 1

Chapter 22 Synthesis and Biophysical Characterization of Stabilized α‐Helices of BCL‐2 Domains

Bird, G. H., Bernal, F., Pitter, K. L., & Walensky, L. D. (2008) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)01622-4 · Cited by 99